AXGN logo

AxoGen (AXGN)

Profile

Full Name

Axogen, Inc.

Ticker Symbol

AXGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

December 17, 1986

Indexes

Not included

Website

http://www.axogeninc.com

Employees

451

Key Details

Price

$18.08

Market Cap

$801.74M(Small cap)

Last Dividend

$1.00

TTM Dividend Yield

-

Annual Revenue

$187.34M(+17.81% YoY)

Annual EPS

-$0.23(+54.90% YoY)

PE Ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$18.08
AXGN price is $18.08

Price All-time High

$55.90
AXGN price is currently -67.66% below its historical high of $55.90

Price Today Change

-2.27%
AXGN price is down -2.27% today

Price YTD Change

+9.71%
AXGN price is up +9.71% since January 1st

Price 1-year Change

+132.69%
AXGN price is up +132.69% year-on-year

Price 3-year Change

+121.57%
AXGN price is up +121.57% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$801.74M
AXGN market capitalization is $801.74 million

Market Cap 3-year Change

+134.06%
AXGN market capitalization is up +134.06% over the past 3 years

Market Cap All-time High

$2.14B
AXGN market capitalization is currently -62.56% below its historical high of $2.14 billion

Market Cap Sector Rank

73.64%
AXGN market capitalization is higher than 73.64% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.5%
AXGN shares outstanding is up +1.5% year-on-year

Shares Outstanding 3-Year Change

+5.65%
AXGN shares outstanding is up +5.65% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.20
AXGN beta is 1.20

200-day SMA

$13.93
AXGN price is currently +29.83% above its 200-day simple moving average

50-day SMA

$18.28
AXGN price is currently -1.09% below its 50-day simple moving average

RSI

52.84
AXGN 14-day relative strength index is 52.84

Volume

1.03
AXGN 30-day relative volume is 1.03

ATR

$0.94
AXGN average true range is $0.94

10-day Historical Volatility

40.82%
AXGN 10-day historical volatility is 40.82%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.00
AXGN last dividend was $1.00 per share, with an ex-dividend date of January 27, 2010

Next Dividend

-
AXGN next dividend has not yet been announced

Dividend per share

Dividend Per Share

-
AXGN annual dividend per share value is unknown

Dividend per share Sector Rank

-
AXGN annual dividend per share is unknown

Dividend per share 1-Year Change

-
AXGN annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
AXGN annual dividend per share 3-year change is unknown

Dividend yield

Dividend Yield

-
AXGN annual dividend yield value is unknown

Dividend yield Sector Rank

-
AXGN annual dividend yield is unknown

Other

Payout Ratio

-
AXGN annual payout ratio value is unknown

Dividends Paid

-
AXGN annual dividends paid value is unknown

Free Cash Flow

$11.00K
AXGN annual free cash flow is $11.00 thousand

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$187.34M
AXGN annual revenue is $187.34 million

Revenue Analysts Estimate

$216.78M
AXGN annual revenue is currently -13.58% lower than the consensus analysts' forecast

Revenue 1-year Change

+17.81%
AXGN annual revenue is up +17.81% year-on-year

Revenue Sector Rank

63.28%
AXGN annual revenue is higher than 63.28% of companies in Healthcare sector

EPS

EPS

-$0.23
AXGN annual earnings per share is -$0.23

EPS Analysts Estimate

$0.28
AXGN annual earnings per share is currently -180.99% lower than the consensus analysts' forecast

EPS 1-year Change

+54.9%
AXGN annual earnings per share is up +54.9% year-on-year

EPS Sector Rank

76.3%
AXGN annual earnings per share is higher than 76.3% of companies in Healthcare sector

Profit

Gross Profit

$141.98M
AXGN annual gross profit is $141.98 million

Gross Margin

75.79%
AXGN annual gross profit margin is 75.79%

Operating Profit

-$3.29M
AXGN annual operating income is -$3.29 million

Operating Margin

-1.75%
AXGN annual operating profit margin is -1.75%

Net Income

-$9.96M
AXGN annual net profit is -$9.96 million

Net Margin

-5.32%
AXGN annual net profit margin is -5.32%

Expenses

Total Expenses

$190.63M
AXGN annual total expenses is $190.63 million

Operating Expenses

$145.26M
AXGN annual total operating expenses is $145.26 million

Cost Of Goods Sold

$45.36M
AXGN annual cost of goods sold is $45.36 million

Selling, General & Administrative Expenses

$117.50M
AXGN annual SGA is $117.50 million

Depreciation And Amortization

$7.84M
AXGN annual depreciation & amortization is $7.84 million

Interest Expense

$8.21M
AXGN annual interest expense is $8.21 million

Income Tax

-
AXGN annual income tax value is unknown

EBIT & EBITDA

EBIT

-$1.76M
AXGN annual earnings before interest & taxes is -$1.76 million

EBITDA

$6.08M
AXGN annual EBITDA is $6.08 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$203.73M
AXGN annual total assets is $203.73 million

Non Current Assets

$104.51M
AXGN annual long term assets is $104.51 million

Current Assets

$99.22M
AXGN annual total current assets is $99.22 million

Cash And Cash Equivalents

$27.55M
AXGN annual cash & cash equivalents is $27.55 million

Accounts Receivable

$24.11M
AXGN annual accounts receivable is $24.11 million

Inventory

$33.18M
AXGN annual inventory is $33.18 million

Liabilities

Total Liabilities

$99.82M
AXGN annual total liabilities is $99.82 million

Long Term Liabilities

$69.21M
AXGN annual total long term liabilities is $69.21 million

Current Liabilities

$30.61M
AXGN annual total current liabilities is $30.61 million

Accounts Payable

$8.01M
AXGN annual accounts payable is $8.01 million

Debt

Total Debt

$68.69M
AXGN annual total debt is $68.69 million

Total Debt 1-year Change

-0.87%
AXGN annual total debt is down -0.87% year-on-year

Long Term Debt

$66.72M
AXGN annual long term debt is $66.72 million

Short Term Debt

$1.97M
AXGN annual short term debt is $1.97 million

Equity & Capital

Shareholders Equity

$103.91M
AXGN annual stockholders equity is $103.91 million

Book Value

$103.91M
AXGN annual book value is $103.91 million

Retained Earnings

-$291.26M
AXGN annual retained earnings is -$291.26 million

Working Capital

$68.61M
AXGN annual working capital is $68.61 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$4.54M
AXGN annual cash flow from operations is $4.54 million

Cash From Operations 1-year Change

+179.34%
AXGN annual cash flow from operations is up +179.34% year-on-year

Cash From Investing

-$10.30M
AXGN annual cash flow from investing activities is -$10.30 million

Cash From Investing 1-year Change

-153.48%
AXGN annual cash flow from investing activities is down -153.48% year-on-year

Cash From Financing

$2.29M
AXGN annual cash flow from financing activities is $2.29 million

Cash From Financing 1-year Change

+17.2%
AXGN annual cash flow from financing activities is up +17.2% year-on-year

CAPEX

CAPEX

$4.52M
AXGN annual capital expenditures is $4.52 million

CAPEX 1-year Change

-69.67%
AXGN annual capital expenditures is down -69.67% year-on-year

Free Cash Flow

Free Cash Flow

$11.00K
AXGN annual free cash flow is $11.00 thousand

Free Cash Flow 1-year Change

+100.05%
AXGN annual free cash flow is up +100.05% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

75.79%
AXGN annual gross profit margin is 75.79%

Operating Margin

-1.75%
AXGN annual operating profit margin is -1.75%

Net Margin

-5.32%
AXGN annual net profit margin is -5.32%

ROA & ROE

ROA

-4.98%
AXGN annual return on assets is -4.98%

ROE

-9.99%
AXGN annual return on equity is -9.99%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
AXGN price to earnings ratio value is unknown

PE Ratio Sector Rank

-
AXGN price to earnings ratio is unknown

PB Ratio

PB Ratio

7.72
AXGN price to book ratio is 7.72

PB Ratio Sector Rank

89.5%
AXGN price to book ratio is higher than 89.5% of companies in Healthcare sector

PS Ratio

PS Ratio

4.28
AXGN price to sales ratio is 4.28

PS Ratio Sector Rank

60.93%
AXGN price to sales ratio is higher than 60.93% of companies in Healthcare sector

Enterprise value

Enterprise Value

$842.87M
AXGN enterprise value is $842.87 million

Enterprise Value Sector Rank

73.67%
AXGN enterprise value is higher than 73.67% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

138.68
AXGN EV/EBITDA is 138.68

EV/EBITDA Sector Rank

99.12%
AXGN EV/EBITDA is higher than 99.12% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

3.24
AXGN annual current ratio is 3.24

Quick Ratio

2.16
AXGN annual quick ratio is 2.16

Leverage

Debt To Equity

0.46
AXGN annual debt to equity ratio is 0.46

Interest Coverage Ratio

-0.21
AXGN annual interest coverage ratio is -0.21

Risk & Stability

Piotroski F-Score

6
AXGN piotroski f-score is 6

Altman Z-Score

4.11
AXGN altman z-score is 4.11

Analyst ratings

Recent major analysts updates

Mar 17, 25 Lake Street
Buy
Mar 5, 25 Citizens Capital Markets
Market Outperform
Mar 5, 25 Cantor Fitzgerald
Overweight
Feb 26, 25 Citizens Capital Markets
Market Outperform
Feb 26, 25 Canaccord Genuity
Buy
Feb 3, 25 Canaccord Genuity
Buy
Aug 9, 24 JMP Securities
Market Outperform
Jul 1, 24 Raymond James
Outperform
Jun 20, 24 Canaccord Genuity
Buy
Jan 19, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

WEAV logo
Weave Communications (WEAV)
MYGN logo
Myriad Genetics (MYGN)
XERS logo
Xeris Biopharma Holdings (XERS)
PHVS logo
Pharvaris NV (PHVS)
RCUS logo
Arcus Biosciences (RCUS)
CMRX logo
Chimerix (CMRX)
ZYME logo
Zymeworks (ZYME)
STAA logo
STAAR Surgical (STAA)
DAWN logo
Day One Biopharmaceuticals (DAWN)
  • What is the ticker symbol for AxoGen?
  • Does AxoGen pay dividends?
  • What sector is AxoGen in?
  • What industry is AxoGen in?
  • What country is AxoGen based in?
  • When did AxoGen go public?
  • Is AxoGen in the S&P 500?
  • Is AxoGen in the NASDAQ 100?
  • Is AxoGen in the Dow Jones?
  • When was AxoGen's last earnings report?
  • When does AxoGen report earnings?
  • Should I buy AxoGen stock now?

What is the ticker symbol for AxoGen?

The ticker symbol for AxoGen is NASDAQ:AXGN

Does AxoGen pay dividends?

No, AxoGen does not pay dividends

What sector is AxoGen in?

AxoGen is in the Healthcare sector

What industry is AxoGen in?

AxoGen is in the Medical Devices industry

What country is AxoGen based in?

AxoGen is headquartered in United States

When did AxoGen go public?

AxoGen's initial public offering (IPO) was on December 17, 1986

Is AxoGen in the S&P 500?

No, AxoGen is not included in the S&P 500 index

Is AxoGen in the NASDAQ 100?

No, AxoGen is not included in the NASDAQ 100 index

Is AxoGen in the Dow Jones?

No, AxoGen is not included in the Dow Jones index

When was AxoGen's last earnings report?

AxoGen's most recent earnings report was on Feb 25, 2025

When does AxoGen report earnings?

The next expected earnings date for AxoGen is May 2, 2025

Should I buy AxoGen stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page